Diffusion into use of exenatide for glucose control in diabetes mellitus : A retrospective cohort study of a new therapySEGAL, Jodi B; DY, Sydney M; MILLMAN, E. Anne et al.Clinical therapeutics. 2007, Vol 29, Num 8, pp 1784-1794, issn 0149-2918, 11 p.Article

Exploring the substitution of exenatide for insulin in patients with type 2 diabetes treated with insulin in combination with oral antidiabetes agentsDAVIS, Stephen N; JOHNS, Don; MAGGS, David et al.Diabetes care. 2007, Vol 30, Num 11, pp 2767-2772, issn 0149-5992, 6 p.Article

Effect of renal impairment on the pharmacokinetics of exenatideLINNEBJERG, Helle; KOTHARE, Prajakti A; PARK, Soomin et al.British journal of clinical pharmacology. 2007, Vol 64, Num 3, pp 317-327, issn 0306-5251, 11 p.Article

Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes : An interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trialsBUSE, John B; KLONOFF, David C; NIELSEN, Loretta L et al.Clinical therapeutics. 2007, Vol 29, Num 1, pp 139-153, issn 0149-2918, 15 p.Article

Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infectionSHEFFIELD, Catherine A; KANE, Michael P; BUSCH, Robert S et al.Pharmacotherapy. 2007, Vol 27, Num 10, pp 1449-1455, issn 0277-0008, 7 p.Article

Animal models of catheter-induced intimal hyperplasia in type 1 and type 2 diabetes and the effects of pharmacologic interventionMCNAMARA, D. B; MURTHY, S. N; FONSECA, A. N et al.Canadian journal of physiology and pharmacology. 2009, Vol 87, Num 1, pp 37-50, issn 0008-4212, 14 p.Article